To examine genes linked to the Alzheimer's
(clinical trials)
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
Alzheimer’s researchers at Penn recently began collaborating on the International Genomics of Alzheimer’s Project to map out the genes that contribute to the disease. This project may lead to the development of drugs and therapies for Alzheimer’s, according to School of Medicine professor Gerard Schellenberg, director of Penn’s Alzheimer’s Disease Genetics Consortium.
Researchers from Penn’s consortium will collaborate with scientists from Institute Pasteur de Lille and Lille University in France, Cardiff University in Wales and the Boston University School of Medicine. “I think if we find genes, we will make a good contribution to understanding the disease, and that helps with drug development and therapies,” Schellenberg said.
Schellenberg, who has focused on researching Alzheimer’s since 1985, also said that the international collaboration will increase the number of Alzheimer’s patients and control subjects involved in the project. “Through this collaboration we can get 25,000 [or] 30,000 people with disease, and the same number without,” Schellenberg said. “We should be able to find additional genes … There’s a great advantage to putting all of this genetic information together.” Read more: dailypennsylvanian.com
Pathways for omega-3 eye benefits
Research in mice has suggested the mechanisms that enable dietary omega-3 fatty acids to help prevent retinopathy, a common eye disease that can lead to blindness in premature babies and diabetics. Read more: nutraingredients.com
No comments:
Post a Comment